Key Publications March 28, 2017

Safety of alirocumab (a PCSK9 monoclonal antibody) from 14 randomized trials.

Am J Cardiol. 2016;118:1805-1811

Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG